| Time | Speaker/Session | Introduction |
|---|---|---|
| 08:00 - 09:00 | Continental Breakfast | |
| 08:45 - 9:00 | Welcome to the Symposium - Opening Remarks: Raj Rajur (CreaGen Inc., Chair, Medicinal Chemistry NESACS) and Mark Ashwell (Nimbus Therapeutics) | |
| Morning Session Chair: Adrian Hobson, Abbvie | ||
| 09:00 - 09:50 | M. Christina White, University of Illinois Title: Late-Stage C—H Functionalization for Diversification |
Introduced by Andrew Scholte (Sanofi) |
| 09:50 - 10:40 | Matthew LaMarche, Novartis Title: Allosteric Inhibition of SHP2 Phosphatase |
Introduced by Lisa Marcaurelle (GSK) |
| 10:40 - 11:10 | Networking break with refreshments & food | |
| 11:10 - 12:00 | Jin-Quan Yu, Scripps Research Institute Title: Molecular Editing through Enantioselective and Remote C–H Activation |
Introduced by Blaise Lippa (Morphic) |
| 12:00 – 14:00 | Lunch Break - Sandwich Buffet | |
| Afternoon Session Chair: Brian Aquila (Alkermes) | ||
| 14:00 - 14:50 | Nate Fuller, Alkermes Title: To Be Announced |
Introduced by Brian Aquila (Alkermes) |
| 14:50 - 15:40 | Rebecca T. Ruck, Merck Title: Enabling Technologies for the Development of Best Process |
Introduced by Scott Edmondson (AstraZeneca) |
| 15:40 - 16:10 | Networking break with refreshments & food | |
| 16:10 - 17:00 |
Keynote Presentation: Prof. Robert Grubbs, Nobel Laureate, California Institute of Technology Title: To Be Announced |
Introduced by Brian Aquila |
| 17:00 - 18:00 | Closing remarks Dan Elbaum (QurAlis)
Social Networking with beer, wine & food - NESACS |
|